Keros Therapeutics IncNASDAQ:KROS
- LAST PRICE57.8600
- TODAY'S CHANGE (%)3.6700 (6.7725%)
- Bid / Lots47.5000/ 1
- Ask / Lots68.0000/ 1
- Open / Previous Close54.6800 / 54.1900
- Day Range
- 52 Week Range
- Volume291,970
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KROS |
|---|---|---|
| 09:32 ET | 710 | 54.68 |
| 09:34 ET | 1100 | 54.48 |
| 09:38 ET | 171 | 53.69 |
| 09:43 ET | 200 | 54.33 |
| 09:45 ET | 467 | 54.8 |
| 09:56 ET | 100 | 55.25 |
| 09:57 ET | 1053 | 55.63 |
| 10:01 ET | 1065 | 55.57 |
| 10:06 ET | 100 | 55.34 |
| 10:08 ET | 300 | 55.14 |
| 10:10 ET | 200 | 55.24 |
| 10:15 ET | 116 | 55.215 |
| 10:17 ET | 1192 | 55.39 |
| 10:19 ET | 229 | 55.33 |
| 10:24 ET | 700 | 55.38 |
| 10:26 ET | 2000 | 55.33 |
| 10:28 ET | 327 | 55.37 |
| 10:30 ET | 540 | 55.435 |
| 10:33 ET | 3979 | 55.385 |
| 10:35 ET | 747 | 55.395 |
| 10:37 ET | 200 | 55.385 |
| 10:39 ET | 206 | 55.51 |
| 10:42 ET | 700 | 55.43 |
| 10:46 ET | 2000 | 55.5 |
| 10:50 ET | 100 | 55.475 |
| 10:51 ET | 515 | 55.475 |
| 10:53 ET | 100 | 55.47 |
| 10:55 ET | 1953 | 55.54 |
| 10:57 ET | 200 | 55.66 |
| 11:00 ET | 550 | 56.33 |
| 11:04 ET | 2015 | 56.57 |
| 11:06 ET | 3581 | 56.5 |
| 11:08 ET | 300 | 56.495 |
| 11:09 ET | 100 | 56.385 |
| 11:11 ET | 600 | 56.23 |
| 11:13 ET | 300 | 56.52 |
| 11:18 ET | 200 | 56.38 |
| 11:20 ET | 100 | 56.435 |
| 11:22 ET | 100 | 56.475 |
| 11:24 ET | 100 | 56.38 |
| 11:26 ET | 400 | 56.52 |
| 11:29 ET | 100 | 56.53 |
| 11:31 ET | 200 | 56.545 |
| 11:36 ET | 1100 | 56.91 |
| 11:38 ET | 799 | 57.17 |
| 11:40 ET | 100 | 57.15 |
| 11:42 ET | 1400 | 56.86 |
| 11:44 ET | 800 | 57.21 |
| 11:54 ET | 301 | 57.4 |
| 11:58 ET | 200 | 57.36 |
| 12:00 ET | 4064 | 57.78 |
| 12:02 ET | 200 | 58.28 |
| 12:03 ET | 200 | 58.195 |
| 12:05 ET | 860 | 58.095 |
| 12:07 ET | 1103 | 58.16 |
| 12:09 ET | 100 | 58.23 |
| 12:16 ET | 380 | 58.18 |
| 12:18 ET | 200 | 58.4 |
| 12:20 ET | 400 | 58.36 |
| 12:21 ET | 1100 | 58.025 |
| 12:25 ET | 3600 | 57.79 |
| 12:27 ET | 500 | 57.46 |
| 12:34 ET | 868 | 57.43 |
| 12:39 ET | 600 | 57.11 |
| 12:43 ET | 1845 | 57.19 |
| 12:45 ET | 100 | 57.175 |
| 12:48 ET | 100 | 57.185 |
| 12:52 ET | 267 | 57.22 |
| 12:54 ET | 2600 | 57.61 |
| 12:57 ET | 474 | 57.8 |
| 12:59 ET | 100 | 57.845 |
| 01:06 ET | 100 | 57.895 |
| 01:08 ET | 145 | 57.85 |
| 01:10 ET | 100 | 57.835 |
| 01:14 ET | 100 | 57.91 |
| 01:15 ET | 500 | 58.0325 |
| 01:17 ET | 900 | 58.13 |
| 01:21 ET | 100 | 58.18 |
| 01:24 ET | 300 | 58.21 |
| 01:26 ET | 1407 | 57.9 |
| 01:28 ET | 505 | 57.58 |
| 01:35 ET | 137 | 57.6687 |
| 01:37 ET | 416 | 57.55 |
| 01:39 ET | 508 | 57.73 |
| 01:42 ET | 600 | 57.595 |
| 01:44 ET | 100 | 57.68 |
| 01:46 ET | 200 | 57.65 |
| 01:48 ET | 200 | 57.59 |
| 01:50 ET | 400 | 57.68 |
| 01:55 ET | 100 | 57.73 |
| 01:57 ET | 201 | 57.735 |
| 02:00 ET | 800 | 57.685 |
| 02:02 ET | 100 | 57.82 |
| 02:04 ET | 100 | 57.77 |
| 02:08 ET | 500 | 57.925 |
| 02:11 ET | 100 | 57.92 |
| 02:13 ET | 100 | 57.92 |
| 02:15 ET | 1271 | 57.865 |
| 02:18 ET | 500 | 58.07 |
| 02:20 ET | 1200 | 57.945 |
| 02:22 ET | 100 | 57.855 |
| 02:24 ET | 400 | 57.89 |
| 02:26 ET | 100 | 57.88 |
| 02:29 ET | 134 | 57.9235 |
| 02:31 ET | 600 | 57.895 |
| 02:33 ET | 200 | 57.875 |
| 02:36 ET | 100 | 57.93 |
| 02:38 ET | 1500 | 57.645 |
| 02:40 ET | 290 | 57.7 |
| 02:42 ET | 300 | 57.65 |
| 02:44 ET | 100 | 57.74 |
| 02:51 ET | 444 | 58.033 |
| 02:54 ET | 200 | 58.045 |
| 02:56 ET | 1315 | 57.95 |
| 02:58 ET | 800 | 57.92 |
| 03:03 ET | 700 | 57.875 |
| 03:05 ET | 100 | 57.8 |
| 03:09 ET | 200 | 57.95 |
| 03:12 ET | 402 | 57.98 |
| 03:16 ET | 200 | 58.02 |
| 03:18 ET | 2071 | 57.925 |
| 03:20 ET | 300 | 58 |
| 03:21 ET | 301 | 58.04 |
| 03:23 ET | 594 | 58.11 |
| 03:25 ET | 772 | 58.24 |
| 03:27 ET | 700 | 58.23 |
| 03:30 ET | 677 | 58.35 |
| 03:32 ET | 3900 | 58.1 |
| 03:34 ET | 562 | 58.055 |
| 03:36 ET | 1000 | 57.87 |
| 03:38 ET | 212 | 57.825 |
| 03:39 ET | 687 | 57.99 |
| 03:41 ET | 1872 | 58.11 |
| 03:43 ET | 1670 | 57.92 |
| 03:45 ET | 906 | 57.815 |
| 03:48 ET | 800 | 57.605 |
| 03:50 ET | 2412 | 57.62 |
| 03:52 ET | 1700 | 57.7 |
| 03:54 ET | 1513 | 57.79 |
| 03:56 ET | 3889 | 57.94 |
| 03:57 ET | 5083 | 57.99 |
| 03:59 ET | 8015 | 57.86 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Keros Therapeutics Inc | 2.0B | -11.1x | --- |
Rocket Pharmaceuticals Inc | 2.0B | -7.5x | --- |
Dyne Therapeutics Inc | 2.0B | -6.3x | --- |
Sana Biotechnology Inc | 1.9B | -6.0x | --- |
Geron Corp | 2.1B | -11.7x | --- |
Structure Therapeutics Inc | 1.8B | -15.5x | --- |
Company Information
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel therapeutics to treat a range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-B), family of proteins. Its lead product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, and in patients with myelofibrosis. Its second product candidate, KER-012, is being developed for the treatment of pulmonary arterial hypertension, or PAH, and for the treatment of cardiovascular disorders. Its third product candidate, KER-065, is being developed for the treatment of obesity and for the treatment of neuromuscular diseases. KER-050 is designed to raise red blood cell and platelet production by inhibiting the signaling of a subset of the TGF-B family of proteins to promote hematopoiesis.
Contact Information
- Headquarters
- 1050 Waltham Street, Suite 302LEXINGTON, MA, United States 02421
- Phone
- 617-314-6297
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ran Nussbaum
- Chief Executive Officer, Director
- Jasbir Seehra
- Chief Financial Officer
- Keith Regnante
- Chief Operating Officer
- Christopher Rovaldi
- Director
- Alpna Seth
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0B |
|---|---|
Revenue (TTM) | $151.0K |
Shares Outstanding | 36.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.33 |
EPS | $-5.19 |
Book Value | $10.43 |
P/E Ratio | -11.1x |
Price/Sales (TTM) | 12,943.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -112,543.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
